Cencora, Inc. $COR Stake Increased by Vestcor Inc

Vestcor Inc increased its stake in Cencora, Inc. (NYSE:CORFree Report) by 373.1% in the fourth quarter, Holdings Channel reports. The institutional investor owned 24,580 shares of the company’s stock after acquiring an additional 19,384 shares during the quarter. Vestcor Inc’s holdings in Cencora were worth $8,302,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Oakworth Capital Inc. bought a new stake in shares of Cencora in the fourth quarter worth $26,000. Elyxium Wealth LLC bought a new stake in shares of Cencora in the fourth quarter worth $27,000. Archer Investment Corp increased its stake in shares of Cencora by 134.3% in the fourth quarter. Archer Investment Corp now owns 82 shares of the company’s stock worth $28,000 after buying an additional 47 shares during the last quarter. Optima Capital LLC bought a new stake in shares of Cencora in the fourth quarter worth $31,000. Finally, Basepoint Wealth LLC bought a new stake in shares of Cencora in the fourth quarter worth $32,000. Institutional investors own 97.52% of the company’s stock.

Analyst Ratings Changes

A number of analysts recently issued reports on the stock. Evercore set a $360.00 price target on shares of Cencora in a research note on Wednesday, April 8th. Robert W. Baird decreased their price objective on shares of Cencora from $420.00 to $339.00 and set an “outperform” rating for the company in a report on Thursday, May 7th. JPMorgan Chase & Co. increased their target price on shares of Cencora from $417.00 to $419.00 and gave the stock an “overweight” rating in a report on Tuesday, February 10th. Barclays raised their price target on shares of Cencora from $400.00 to $425.00 and gave the stock an “overweight” rating in a research report on Friday, February 13th. Finally, William Blair assumed coverage on shares of Cencora in a research report on Tuesday, April 28th. They set a “market perform” rating for the company. Twelve investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $380.25.

View Our Latest Stock Report on COR

Cencora Price Performance

Shares of NYSE:COR opened at $274.94 on Friday. The company has a quick ratio of 0.59, a current ratio of 0.95 and a debt-to-equity ratio of 3.40. Cencora, Inc. has a fifty-two week low of $244.82 and a fifty-two week high of $377.54. The firm has a 50-day simple moving average of $292.70 and a 200 day simple moving average of $330.55. The company has a market cap of $53.49 billion, a PE ratio of 21.08, a P/E/G ratio of 1.46 and a beta of 0.59.

Cencora (NYSE:CORGet Free Report) last announced its quarterly earnings data on Wednesday, May 6th. The company reported $4.75 earnings per share for the quarter, missing analysts’ consensus estimates of $4.82 by ($0.07). Cencora had a net margin of 0.78% and a return on equity of 135.20%. The business had revenue of $78.36 billion for the quarter, compared to the consensus estimate of $81.09 billion. During the same period in the prior year, the company earned $4.42 EPS. Cencora’s quarterly revenue was up 3.9% on a year-over-year basis. Cencora has set its FY 2026 guidance at 17.650-17.900 EPS. On average, sell-side analysts anticipate that Cencora, Inc. will post 17.79 EPS for the current year.

Cencora declared that its Board of Directors has initiated a stock repurchase plan on Thursday, May 21st that permits the company to buyback $2.00 billion in shares. This buyback authorization permits the company to buy up to 3.9% of its shares through open market purchases. Shares buyback plans are usually an indication that the company’s board believes its stock is undervalued.

Cencora Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Monday, June 1st. Stockholders of record on Friday, May 15th were issued a dividend of $0.60 per share. The ex-dividend date of this dividend was Friday, May 15th. This represents a $2.40 annualized dividend and a dividend yield of 0.9%. Cencora’s payout ratio is 18.40%.

Cencora Company Profile

(Free Report)

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.

Further Reading

Want to see what other hedge funds are holding COR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cencora, Inc. (NYSE:CORFree Report).

Institutional Ownership by Quarter for Cencora (NYSE:COR)

Receive News & Ratings for Cencora Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cencora and related companies with MarketBeat.com's FREE daily email newsletter.